sodium;3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylic acid;methyl 3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylate;hydroxide

C81H93N6NaO7 — CID 159818735

IUPACsodium;3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylic acid;methyl 3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylate;hydroxide
SMILESCOC(=O)c1ccc2c(C3CCCCC3)c3n(c2c1)CCCn1cc(C2CCN(CCOCc4ccccc4)CC2)c2cccc-3c21.O=C(O)c1ccc2c(C3CCCCC3)c3n(c2c1)CCCn1cc(C2CCN(CCOCc4ccccc4)CC2)c2cccc-3c21.[Na+].[OH-]
InChIInChI=1S/C41H47N3O3.C40H45N3O3.Na.H2O/c1-46-41(45)32-16-17-34-37(26-32)44-21-9-20-43-27-36(30-18-22-42(23-19-30)24-25-47-28-29-10-4-2-5-11-29)33-14-8-15-35(39(33)43)40(44)38(34)31-12-6-3-7-13-31;44-40(45)31-15-16-33-36(25-31)43-20-8-19-42-26-35(29-17-21-41(22-18-29)23-24-46-27-28-9-3-1-4-10-28)32-13-7-14-34(38(32)42)39(43)37(33)30-11-5-2-6-12-30;;/h2,4-5,8,10-11,14-17,26-27,30-31H,3,6-7,9,12-13,18-25,28H2,1H3;1,3-4,7,9-10,13-16,25-26,29-30H,2,5-6,8,11-12,17-24,27H2,(H,44,45);;1H2/q;;+1;/p-1
InChIKeyNLYNYTNGOXCGBW-UHFFFAOYSA-M
MW1285.66 g/mol
LogP14.53
Rot. Bonds16

About sodium;3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylic acid;methyl 3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylate;hydroxide

sodium;3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylic acid;methyl 3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylate;hydroxide (PubChem CID 159818735) has the molecular formula C81H93N6NaO7 and a molecular weight of 1285.66 g/mol. Its IUPAC name is sodium;3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylic acid;methyl 3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylate;hydroxide.

Molecular Properties

Compound Namesodium;3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylic acid;methyl 3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylate;hydroxide
PubChem CID159818735
Molecular FormulaC81H93N6NaO7
Molecular Weight1285.66 g/mol
Exact Mass1284.70
IUPAC Namesodium;3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylic acid;methyl 3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylate;hydroxide
SMILESCOC(=O)c1ccc2c(C3CCCCC3)c3n(c2c1)CCCn1cc(C2CCN(CCOCc4ccccc4)CC2)c2cccc-3c21.O=C(O)c1ccc2c(C3CCCCC3)c3n(c2c1)CCCn1cc(C2CCN(CCOCc4ccccc4)CC2)c2cccc-3c21.[Na+].[OH-]
InChIInChI=1S/C41H47N3O3.C40H45N3O3.Na.H2O/c1-46-41(45)32-16-17-34-37(26-32)44-21-9-20-43-27-36(30-18-22-42(23-19-30)24-25-47-28-29-10-4-2-5-11-29)33-14-8-15-35(39(33)43)40(44)38(34)31-12-6-3-7-13-31;44-40(45)31-15-16-33-36(25-31)43-20-8-19-42-26-35(29-17-21-41(22-18-29)23-24-46-27-28-9-3-1-4-10-28)32-13-7-14-34(38(32)42)39(43)37(33)30-11-5-2-6-12-30;;/h2,4-5,8,10-11,14-17,26-27,30-31H,3,6-7,9,12-13,18-25,28H2,1H3;1,3-4,7,9-10,13-16,25-26,29-30H,2,5-6,8,11-12,17-24,27H2,(H,44,45);;1H2/q;;+1;/p-1
InChIKeyNLYNYTNGOXCGBW-UHFFFAOYSA-M
XLogP14.53
TPSA138.26 Ų
H-Bond Donors1
H-Bond Acceptors12
Rotatable Bonds16
Heavy Atoms95
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001285.66
LogP ≤ 514.53
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze sodium;3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylic acid;methyl 3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylate;hydroxide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of sodium;3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylic acid;methyl 3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylate;hydroxide?
The IUPAC name of sodium;3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylic acid;methyl 3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylate;hydroxide (CID 159818735) is sodium;3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylic acid;methyl 3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylate;hydroxide.
What is the SMILES notation for sodium;3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylic acid;methyl 3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylate;hydroxide?
The canonical SMILES for sodium;3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylic acid;methyl 3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylate;hydroxide is COC(=O)c1ccc2c(C3CCCCC3)c3n(c2c1)CCCn1cc(C2CCN(CCOCc4ccccc4)CC2)c2cccc-3c21.O=C(O)c1ccc2c(C3CCCCC3)c3n(c2c1)CCCn1cc(C2CCN(CCOCc4ccccc4)CC2)c2cccc-3c21.[Na+].[OH-].
What is the InChIKey of sodium;3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylic acid;methyl 3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylate;hydroxide?
The InChIKey is NLYNYTNGOXCGBW-UHFFFAOYSA-M. The full InChI is InChI=1S/C41H47N3O3.C40H45N3O3.Na.H2O/c1-46-41(45)32-16-17-34-37(26-32)44-21-9-20-43-27-36(30-18-22-42(23-19-30)24-25-47-28-29-10-4-2-5-11-29)33-14-8-15-35(39(33)43)40(44)38(34)31-12-6-3-7-13-31;44-40(45)31-15-16-33-36(25-31)43-20-8-19-42-26-35(29-17-21-41(22-18-29)23-24-46-27-28-9-3-1-4-10-28)32-13-7-14-34(38(32)42)39(43)37(33)30-11-5-2-6-12-30;;/h2,4-5,8,10-11,14-17,26-27,30-31H,3,6-7,9,12-13,18-25,28H2,1H3;1,3-4,7,9-10,13-16,25-26,29-30H,2,5-6,8,11-12,17-24,27H2,(H,44,45);;1H2/q;;+1;/p-1.
What are the key properties of sodium;3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylic acid;methyl 3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylate;hydroxide?
sodium;3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylic acid;methyl 3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylate;hydroxide has a molecular weight of 1285.66 g/mol, XLogP of 14.53, 16 rotatable bonds, 1 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for sodium;3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylic acid;methyl 3-cyclohexyl-16-[1-(2-phenylmethoxyethyl)piperidin-4-yl]-10,14-diazapentacyclo[12.6.1.02,10.04,9.017,21]henicosa-1(20),2,4(9),5,7,15,17(21),18-octaene-7-carboxylate;hydroxide is sourced from PubChem (CID 159818735), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).